Bio-Techne Income Statement (2009-2026) | TECH

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	259.03M	257.72M	269.28M	290.38M	288.23M	2.00M	271.58M	294.15M	301.32M	276.94M	272.60M	303.43M	306.10M	289.46M	297.03M	316.18M	316.96M	286.56M	295.88M	311.42M
Cost of Revenue (Quarter)	83.08M	86.72M	85.58M	88.92M	87.88M	90.06M	88.22M	91.98M	96.62M	91.74M	96.01M	98.83M	102.75M	106.44M	103.14M	101.62M	118.15M	98.44M	104.60M	103.13M
Gross Profit (Quarter)	175.94M	171.00M	183.69M	201.46M	200.35M	179.59M	183.36M	202.16M	204.70M	185.19M	176.59M	204.60M	203.35M	183.02M	193.89M	214.56M	198.81M	188.11M	191.28M	208.29M
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	20.72M	21.60M	20.65M	21.74M	23.15M	23.90M	22.46M	22.71M	23.42M	24.00M	22.92M	25.76M	23.99M	23.87M	25.02M	24.58M	26.03M	24.24M	23.12M	23.45M
Selling, General & Administrative (Quarter)	86.64M	86.17M	100.69M	89.27M	96.63M	99.38M	93.01M	99.24M	86.75M	105.33M	115.67M	111.84M	133.54M	119.16M	121.45M	151.27M	196.64M	116.21M	113.69M	109.34M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)	107.36M	107.78M	121.34M	111.01M	119.78M	123.28M	115.47M	121.95M	110.17M	129.33M	138.58M	137.60M	157.53M	143.03M	146.47M	175.85M	222.67M	140.45M	136.82M	132.79M
Operating Income (Quarter)	68.58M	63.22M	62.35M	90.45M	80.57M	56.32M	67.89M	80.21M	94.53M	55.86M	38.00M	67.00M	45.82M	39.99M	47.42M	38.71M	-23.86M	47.66M	54.46M	75.50M
EBIT (Quarter)	68.58M	63.22M	62.35M	90.45M	80.57M	56.32M	67.89M	80.21M	94.53M	55.86M	38.00M	67.00M	45.82M	39.99M	47.42M	38.71M	-23.86M	47.66M	54.46M	75.50M
Non-operating items
Non Operating Investment Income (Quarter)						49.77M	-0.07M	0.31M	-0.68M	0.28M
Interest & Investment Income (Quarter)	0.17M	0.19M	0.24M	0.17M	0.19M	0.43M	0.97M	0.97M	1.03M	0.89M	0.82M	0.71M	0.91M	0.93M	1.35M	1.03M	0.58M	0.97M	0.90M	0.98M
Other Non Operating Income (Quarter)	1.57M	7.38M	26.49M	7.18M	2.52M	4.70M	-0.69M	-1.71M	2.49M	-0.35M	-3.67M	0.34M	-4.90M	-3.03M	-0.04M	-1.71M	5.62M	-1.67M	-0.71M	-0.16M
Non Operating Income (Quarter)	-61.47M	4.16M	23.83M	-21.68M	-1.52M	47.40M	-1.46M	-0.01M	-6.21M	-6.30M	-4.62M	-5.91M	-4.16M	0.18M	-4.54M	-0.43M	1.00M	0.33M	-3.68M	-4.27M
Net income details
EBT (Quarter)	7.11M	67.38M	86.18M	68.77M	79.05M	103.72M	66.43M	80.20M	88.32M	49.56M	33.39M	61.08M	30.78M	40.17M	42.88M	38.27M	-109.67M	47.99M	50.78M	71.22M
Tax Provisions (Quarter)	20.48M	-1.60M	14.12M	8.63M	10.07M	13.98M	16.42M	9.98M	12.83M	-1.44M	5.92M	12.03M	41.23M	6.57M	7.99M	15.69M	-5.18M	9.81M	12.78M	20.18M
Profit After Tax (Quarter)	-18.22M	68.98M	72.06M	60.74M	-219.09M	89.73M	50.01M	70.22M	75.48M	50.99M	41.82M	49.06M	28.34M	33.60M	9.33M	26.19M	-13.94M	33.67M	40.06M	51.05M
Income from Non-Controlling Interests (Quarter)	0.09M	-0.63M	0.07M	-0.00M	9.27M	-0.03M	0.21M		-0.21M
Income from Continuing Operations (Quarter)	-13.37M	68.98M	72.06M	60.14M	68.98M	89.73M	50.01M	70.22M	75.48M	50.99M	27.46M	49.06M	-10.46M	33.60M	34.89M	22.59M	-104.49M	38.19M	38.01M	51.05M
Consolidated Net Income (Quarter)	-13.37M	68.98M	72.06M	60.14M	68.98M	89.73M	50.01M	70.22M	75.48M	50.99M	27.46M	49.06M	-10.46M	33.60M	34.89M	22.59M	-104.49M	38.19M	38.01M	51.05M
Income towards Parent Company (Quarter)	-13.37M	68.98M	72.06M	60.14M	68.98M	89.73M	50.01M	70.22M	75.48M	50.99M	27.46M	49.06M	-10.46M	33.60M	34.89M	22.59M	-104.49M	38.19M	38.01M	51.05M
Net Income towards Common Stockholders (Quarter)	-13.37M	68.98M	72.06M	60.14M	68.98M	89.73M	50.01M	70.22M	75.48M	50.99M	27.46M	49.06M	-10.46M	33.60M	34.89M	22.59M	-104.49M	38.19M	38.01M	51.05M
Additional items
EPS (Basic) (Quarter)	-0.09	0.44	0.46	0.38	0.44	0.57	0.32	0.45	0.48	0.32	0.17	0.31	-0.07	0.21	0.22	0.14	-0.66	0.25	0.24	0.33
EPS (Diluted) (Quarter)	-0.08	0.42	0.44	0.37	0.42	0.55	0.31	0.43	0.47	0.31	0.17	0.31	-0.07	0.21	0.22	0.14	-0.65	0.24	0.24	0.32
Shares Outstanding (Quarter)	154.99M	156.38M	157.24M	157.09M	156.88M	156.93M	157.01M	157.31M	157.18M	158.13M	157.53M	157.31M	157.71M	158.53M	158.43M	157.37M	157.52M	155.46M	155.84M	156.33M
Shares Outstanding (Diluted) (Quarter)	161.93M	164.63M	164.83M	163.88M	164.12M	162.17M	161.75M	161.62M	161.85M	161.94M	160.06M	160.50M	160.77M	161.12M	160.63M	158.94M	159.72M	156.36M	157.00M	157.40M
Shares Outstanding (Entity) (Quarter)	155.82M	157.09M	157.28M	157.05M	156.64M	156.93M	157.09M	157.34M	157.64M	158.35M	157.14M	157.55M	158.22M	158.88M	157.92M	156.76M	154.97M	155.75M	155.88M	156.52M
EBITDA (Quarter)	68.58M	63.22M	62.35M	90.45M	80.57M	56.32M	67.89M	80.21M	94.53M	55.86M	38.00M	67.00M	45.82M	39.99M	47.42M	38.71M	-23.86M	47.66M	54.46M	75.50M
Interest Expenses (Quarter)	3.29M	12.46M	10.23M	61.88M	2.79M	57.18M	57.33M	57.82M	7.42M	59.31M	57.73M	57.38M	4.50M	46.20M	45.91M	46.05M	-3.83M	26.91M	26.92M	26.91M
Tax Rate (Quarter)	287.95%	-2.37%	16.38%	12.55%	12.74%	13.48%	24.72%	12.44%	14.53%	-2.90%	17.74%	19.69%	133.97%	16.36%	18.63%	40.98%	4.72%	20.43%	25.16%	28.33%

Research Tools

Developers

Bio-Techne Income Statement (2009-2026) | TECH

Research Tools

Developers

Bio-Techne Income Statement (2009-2026) | TECH

Create an account

Sign In

Reset Password